Cure Today18h
An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.
Constipation Treatment - Global and Regional Markets Analysis, 2025-2030 - Increasing Demand for OTC Laxatives and Natural Remedies
Constipation Treatment Market Constipation Treatment Market Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Constipation Treatment - Global Strategic Business Report" has been added to ...